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To the editor:
We read with great interest the article “Isolated Chorea Associated 
with LGI1 Antibody” (LGI1, leucine-rich glioma inactivated 1) by Ram-
dhani and Frucht.1 The authors presented an important clinical obser-
vation about a treatable etiology of chorea in a 53-year-old male, in 
whom an underlying tumor could not be detected. By presenting a case 
vignette of hemichorea associated with antibodies against contactin-
associated protein 2 (CASPR2), we wish to emphasize the relationship 
between a movement disorder and an autoantibody. In our patient, lung 
cancer was detected.
A 75-year-old female developed choreiform movement disorder, 
predominantly affecting the left limbs and the left side of the face. She 
took no neuroleptic drugs and reported that she had been smoking for 
about 50 years. Her family history was unremarkable. Cranial magnetic 
resonance images and serum chemistry, including liver enzymes, com-
plete blood count, thyroid function, and cerebrospinal fluid analysis 
were negative. Her creatine kinase level was slightly elevated, due to the 
movement disorder (325 U/L, normal <140). Systemic lupus erythemato-
sus and neuroacanthocytosis were not clinically suspected, and tests for 
these conditions were not performed. Electroencephalography (EEG) 
revealed normal background activity without signs of epileptic dis-
charges. As a paraneoplastic process was suspected,2 computed tomog-
raphy-positron emission tomography (CT-PET) was performed and 
revealed a right-side malignant lung tumor. Based on the patient’s histo-
ry and radiological presentation, it was perceived as smoking-associated 
lung cancer. Serum analysis for paraneoplastic autoantibodies detected 
CASPR2 antibodies by indirect immunofluorescence test (titer IgM 1:10; 
Euroimmun, Lübeck, Germany). Tests for the remainder of the autoan-
tibodies (anti-Hu, -Ri, -Yo, -CV2, -Ma, -Ta, -PCA2, -ANNA, -NMDA, 
-AMPA-1, and -AMPA-2) were negative. Symptomatic treatment with 
tiapride (200 mg daily) was introduced and resulted in acceptable symp-
tom control within the following 2 days. Although oncologic therapy 
was proposed, it was refused by the patient.
Through this case vignette, we wish to complement the observa-
tions of Ramdhani and Frucht1 and Tofaris et al.3 for two reasons. First, 
autoimmune processes (both paraneoplastic and idiopathic) are well-
recognized causes of chorea but are relatively rare.4 In most cases, co-
existing neurological findings, such as peripheral neuropathy, cognitive 
decline, epilepsy, or oculomotor disturbances, are present.5 In the Ram-
dhani and Frucht1 case, and even in our case, isolated chorea and hemi-
chorea, respectively, were the index symptom. Whereas an idiopathic 
etiology was strongly assumed in the case of Ramdhani and Frucht,1 in 
our case, an obvious paraneoplastic etiology has to be considered. The 
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pronounced CT-PET-findings and the history of excessive smoking led 
us to suspect a smoking-associated lung cancer. However, a histological 
tissue diagnosis was refused by the patient, as was subsequent oncologic 
therapy. Second, the isolated pattern of CASPR2 autoantibody positiv-
ity is interesting. Only one case of autoimmune chorea with a positive 
CASPR2 antibody has been reported, and it was an idiopathic case. This 
is according to a study on autoimmune chorea in adults,4 in which the 
case of Ramdhani and Frucht1 can also be grouped. In the paraneoplas-
tic group of autoimmune chorea, CASPR2 has not yet been reported.4 
On the other hand, CASPR2 is more often associated with neuromyoto-
nia and Morvan syndrome and occurs more often in thymoma,6 though 
these clinical findings were not present in our patient. However, it is 
informative that LGI1 (the antibody detected in the patients of Ramd-
hani and Frucht1 and of Toranis et al.3) and CASPR2 are taken together 
as voltage-gated potassium channel (VGKC) complex autoantibodies 
and thus share substantial similarity.7,8 To conclude, autoimmune pro-
cesses must be considered in the differential diagnosis of adult-onset 
chorea. Besides laboratory and cerebrospinal fluid analysis,9,10 a serum 
panel of autoantibodies, including LGI1 and CASPR2, may contribute 
to the diagnosis. 
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